First oral medication approved for psoriasis by J&J.
Rivals the effectiveness of existing injectable treatments.
Expected to impact the psoriasis treatment market significantly.
Briefing: J&J Wins Approval for First-of-its-Kind Psoriasis Pill
Strategic angle: Johnson & Johnson's new daily psoriasis pill offers benefits comparable to injectable treatments, potentially disrupting a multibillion-dollar market.